Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(13%)
Results Posted
20%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_1
6
75%
Ph phase_2
2
25%

Phase Distribution

6

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
6(75.0%)
Phase 2Efficacy & side effects
2(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)

Detailed Status

Completed5
Active, not recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 16 (75.0%)
Phase 22 (25.0%)

Trials by Status

completed563%
active_not_recruiting113%
withdrawn113%
terminated113%

Recent Activity

1 active trials
Showing 5 of 8
completedphase_1

Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes

NCT00708604
active_not_recruitingphase_1

Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen

NCT00706420
terminatedphase_1

Islet Cell Transplants for Diabetes

NCT00303134
completedphase_1

Pancreatic Islet Cell Transplantation

NCT00214786
completedphase_1

Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment

NCT00530686
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00708604Phase 1

Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes

Completed
NCT00706420Phase 1

Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen

Active Not Recruiting
NCT00303134Phase 1

Islet Cell Transplants for Diabetes

Terminated
NCT00214786Phase 1

Pancreatic Islet Cell Transplantation

Completed
NCT00530686Phase 1

Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment

Completed
NCT03047200Phase 1

Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression

Withdrawn
NCT00021788Phase 2

Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression

Completed
NCT00021801Phase 2

Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen

Completed

All 8 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
8